Obtaining real-world evidence: the Salford Lung Study
Open Access
Abstract
We need to assess clinical treatments in real-life settings outside of randomised controlled trials (RCTs). Pragmatic RCT (pRCT) data can supplement RCTs by providing effectiveness information to support healthcare decisions. Electronic health records can facilitate concurrent safety monitoring and data collection without direct patient contact for large randomised study populations in pRCTs. The Salford Lung Study is the world's first phase III pRCT in asthma and chronic obstructive pulmonary disease (COPD), which aims to randomise over 7000 patients. This paper describes the hurdles overcome and the enormous effort and resource required to establish this comparative effectiveness study of a prelicence intervention. GlaxoSmithKline protocol HZC115151 Asthma study clinicaltrials.gov registration NCT01706198 COPD study clinicaltrials.gov registration NCT01551758Keywords
This publication has 4 references indexed in Scilit:
- Obtaining real-world evidence: the Salford Lung StudyThorax, 2014
- The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness researchClinical Trials, 2012
- Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force ReportValue in Health, 2012
- How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?Respiratory Medicine, 2005